Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 122833
Published online Jan 14, 2027. doi: 10.3748/wjg.122833
Published online Jan 14, 2027. doi: 10.3748/wjg.122833
Table 6 Postoperative morbidity and mortality after liver resection, n (%)
| Variable | Neoadjuvant therapy (n = 56) | Upfront surgery (n = 47) | P value |
| Clavien-Dindo grade ≥ III | 2 (3.6) | 3 (6.4) | 0.658 |
| Post-hepatectomy liver failure | 0 (0) | 0 (0) | -1 |
| Postoperative hemorrhage | 5 (8.9) | 6 (12.8) | 0.543 |
| Bile leakage | 4 (7.1) | 4 (8.5) | 1.000 |
| Fever | 20 (35.7) | 18 (38.3) | 0.839 |
| Pleural effusion | 3 (5.4) | 4 (8.5) | 0.699 |
| Ascites | 8 (14.3) | 6 (12.8) | 1.000 |
| Reoperation | 0 (0) | 0 (0) | -1 |
| Hypoproteinemia | 50 (89.3) | 41 (87.2) | 0.767 |
| 90-day mortality | 0 (0) | 2 (4.3) | 0.206 |
- Citation: Lang MR, Han RY, Zhu FY, Wang ZH, Zhai JX, Luo M, Hu YW, Tao CC, Siqin TN, Sun J, Lu ZY, Zhao JJ, Tong JX, Wang X, Cao DY, Wang LM, Rong WQ, Wu JX, Meng X, Wang HG. Prognostic impact of neoadjuvant therapy vs upfront surgery in patients with huge hepatocellular carcinoma undergoing curative resection. World J Gastroenterol 2027; 33(2): 122833
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/122833.htm
- DOI: https://dx.doi.org/10.3748/wjg.122833